TY - GEN 
AU - Serrano-Mayorga C.C
AU - Duque S
AU - Ibáñez-Prada E.D
AU - Garcia-Gallo E
AU - Arrieta M.P.R
AU - Bastidas A
AU - Rodríguez A
AU - Martin-Loeches I
AU - Reyes L.F.
PY - 2024
SN - 20452322
UR - http://hdl.handle.net/10818/61866
AB - Cefepime and piperacillin/tazobactam are antimicrobials recommended by IDSA/ATS guidelines for the empirical management of patients admitted to the intensive care unit (ICU) with community-acquired pneumonia (CAP). Concerns have been raised about...
LA - eng
PB - Scientific Reports
KW - Cefepime
KW - Community-acquired pneumonia (CAP)
KW - Intensive care unit (ICU)
KW - Piperacillin/tazobactam
KW - Targeted maximum likelihood estimation (TMLE)
TI - A targeted likelihood estimation comparing cefepime and piperacillin/tazobactam in critically ill patients with community-acquired pneumonia (CAP)
DO - 10.1038/s41598-024-64444-3
ER -